Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 1 single and multiple ascending dose clinical study of TERN-501

Next Previous
Trial Profile

Phase 1 single and multiple ascending dose clinical study of TERN-501

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 27 Jun 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs TERN-501 (Primary)
  • Indications Non-alcoholic steatohepatitis
  • Focus Adverse reactions; First in man; Pharmacokinetics; Proof of concept
  • Sponsors Terns Pharmaceuticals

Most Recent Events

  • 08 Jun 2022 According to a Terns Pharmaceuticals media release, results from this trial were accepted for presentation at the European Association for the Study of the Liver (EASL) International Liver Congress (ILC) 2022 and abstracts were published in the July supplement of the Journal of Hepatology.
  • 12 Nov 2021 According to a Terns Pharmaceuticals media release, data from this study was presented at The Liver Meeting Digital Experience 2021, the annual meeting of the American Association for the Study of Liver Diseases (AASLD)
  • 12 Nov 2021 Results published in Terns Pharmaceuticals Media Release

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top